ANUSIYANTHAN MARIAMPILLAI
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology ANCHORAGE, AK NPI 1518221977
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology AK Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$4,261.40
- Category: General Payments
- Program years: PY2018–2024
- Record count: 51
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $554.92 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $554.92 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $228.33 | 3 |
| Genmab U.S., Inc. | $115.06 | 1 |
| Acerta Pharma LLC | $106.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $80.15 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $25.38 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086128586 | Bayer Healthcare Pharmaceuticals Inc. | $25.38 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089452384 | Daiichi Sankyo Inc. | $86.28 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089452386 | Daiichi Sankyo Inc. | $73.76 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089452388 | Daiichi Sankyo Inc. | $68.29 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101437585 | E.R. Squibb & Sons, L.L.C. | $80.15 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105691657 | AstraZeneca Pharmaceuticals LP | $106.00 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126824463 | Genmab U.S., Inc. | $115.06 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.